Incidence, Risk Factors, and Outcomes in Stressor-Associated Atrial Fibrillation: Insights From the VITAL-AF Trial
Among >30 000 primary care patients with adjudicated AF events, nearly one-third of incident AF cases were stressor associated. Despite similar risk factor profiles and comparably high rates of adverse outcomes, oral anticoagulant initiation is lower when AF is stressor associated. Future work is needed to define optimal approaches to prevention, surveillance, and management of stressor-associated AF.
Authors
- Daniel E. Singer (ORCID: https://orcid.org/0000-0001-6145-4848)
- Shinwan Kany (ORCID: https://orcid.org/0000-0001-8113-733X)
- Leila H. Borowsky (ORCID: https://orcid.org/0000-0001-7498-4450)
- Shaan Khurshid (ORCID: https://orcid.org/0000-0002-2840-4539)
- Steven A. Lubitz (ORCID: https://orcid.org/0000-0002-9599-4866)
- Yuchiao Chang (ORCID: https://orcid.org/0000-0003-1093-3755)
- David D. McManus (ORCID: https://orcid.org/0000-0002-9343-6203)
- Steven J. Atlas (ORCID: https://orcid.org/0000-0002-2297-9614)
- Patrick T. Ellinor (ORCID: https://orcid.org/0000-0002-2067-0533)
- Julian S. Haimovich (ORCID: https://orcid.org/0000-0003-4346-6241)
Institutions
- Broad Institute (US)
- Harvard University (US)
- Universität Hamburg (DE)
- University of Massachusetts Chan Medical School (US)
- Massachusetts General Hospital (US)
- Heart Foundation (US)
- University Medical Center Hamburg-Eppendorf (DE)
- Mass General Brigham (US)
Publication Details
- Journal
- Circulation
- Published
- 2025-11-08
- DOI
- https://doi.org/10.1161/circulationaha.125.076421
- Citations
- 1
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.39